Southwest Idaho Bridges to Baccalaureate Program
西南爱达荷州通往学士学位课程的桥梁
基本信息
- 批准号:10674997
- 负责人:
- 金额:$ 6.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:Biomedical ResearchDataDegree programEnrollmentFellowshipFundingFunding MechanismsFutureGoalsGraduation RatesIdahoIndividualInstitutionMentorsMentorshipParticipantResearchScienceSelf AssessmentStudentsUnderrepresented PopulationsUnderrepresented StudentsUnited States National Institutes of HealthUniversitiesbridge to the baccalaureatecareercohortcollegecommunity collegecourse developmentexperiencefaculty mentorimprovedinterestpeer coachingprogramsrecruitretention ratestatisticsstudent participationsuccesstransfer studentundergraduate research experienceuniversity student
项目摘要
PROGRAM SUMMARY
The Southwest Idaho Bridges to the Baccalaureate (SWID B2B) program is an enduring undergraduate
research program in Idaho that supports both the transition of underrepresented (UR) students from the College
of Western Idaho (CWI) community college into biomedical degree programs at Boise State University (BSU)
and their successful graduation. The SWID B2B program was originally developed using a previous NIH R25
funding mechanism and will be entering its second five-year span under the T34 mechanism. Based on statistics
from our institutional self-assessments, the SWID B2B program has the long-term goal of increasing the number
of individuals from UR groups in Idaho that pursue research careers in the biomedical sciences. The short-term
goals of this T34-funded B2B program are to i) increase the number of UR CWI community college students that
transfer to BSU into biomedical science majors, ii) increase retention and graduation rates for UR biomedical
science transfer students, and iii) prepare UR students for careers in the biomedical sciences. In steady state,
this program will serve hundreds of students per year and include annual B2B cohorts of 10 UR students. To
accomplish our goals, we request funding for the following five specific aims. Aim 1. Recruit and select
program participants. The objective of this aim is to Recruit UR students with strong potential interests in
futures that include biomedical research and to Select UR students (in cohorts of 10 per year) into the B2B
program. Aim 2. Advise and prepare student trainees. The object of this aim is to Advise CWI students early
and continuously through program ambassadors and to Prepare students for a research experience by offering
B2B-enhanced courses at CWI and providing peer mentoring. Aim 3. Immerse and include student trainees.
The objective of this aim is to Immerse community college students in a biomedical research experience with a
faculty mentor during the summer before they transfer to the university campus and to Include students in the
everyday activities associated with biomedical research. Aim 4. Equip and support student trainees. The
objective of this aim is to Equip students as they move through their degree program at BSU by providing an
academic-year research experience and a professional development course, as well as to Support students for
success by providing them continued scientific mentorship and the opportunity to present their research data
nationally. Aim 5. Continually engage and launch program participants. The objective of this aim is to
Continually Engage students as they leave SWID B2B and move through their degree program at BSU by
encouraging all students to continue their research in their mentor’s lab, enroll in a senior level seminar course,
and when appropriate, apply for additional summer fellowships. Studies have demonstrated that undergraduate
research experiences like the B2B program have an important positive impact on UR groups, and we expect that
our SWID B2B program will have enduring effects, transform the lives of UR students, and improve their success
as they move forward into biomedical careers.
计划概要
西南爱达荷大学桥梁课程 (SWID B2B) 项目是一项持久的本科课程
爱达荷州的一项研究计划,支持学院中代表性不足 (UR) 学生的过渡
西爱达荷州 (CWI) 社区学院转入博伊西州立大学 (BSU) 生物医学学位课程
他们的成功毕业 SWID B2B 程序最初是使用以前的 NIH R25 开发的。
据统计,T34机制将进入第二个五年跨度。
从我们的机构自我评估来看,SWID B2B 计划的长期目标是增加数量
来自爱达荷州 UR 团体的个人从事生物医学科学研究。
该 T34 资助的 B2B 计划的目标是 i) 增加 UR CWI 社区学院学生的数量
转学到 BSU 生物医学科学专业,ii) 提高 UR 生物医学的保留率和毕业率
科学转学生,以及 iii) 为 UR 学生在稳定状态下从事生物医学科学职业做好准备,
该计划每年将为数百名学生提供服务,其中包括每年 10 名 UR 学生组成的 B2B 群体。
目标 1. 招募和选拔
该项目的目标是招募对以下领域有强烈潜在兴趣的 UR 学生。
包括生物医学研究在内的未来,并选择 UR 学生(每年 10 人)进入 B2B
目标 2. 为学生学员提供建议和准备 该目标的目的是尽早为 CWI 学生提供建议。
并不断通过项目大使,通过提供
CWI 的 B2B 强化课程并提供同行指导 目标 3. 融入并让学生受训者参与其中。
这一目标的目的是让社区学院的学生沉浸在生物医学研究经验中
在转入大学校园之前,教师会在夏季担任导师,并让学生参与其中
目标 4. 为学员提供装备和支持。
这一目标的目的是通过提供一个
学年的研究经验和专业发展课程,以及支持学生
通过为他们提供持续的科学指导和展示研究数据的机会来取得成功
目标 5. 持续吸引和启动计划参与者。
在学生离开 SWID B2B 并在 BSU 完成学位课程时持续吸引他们
鼓励所有学生继续在导师的实验室进行研究,参加高级研讨会课程,
在适当的时候,申请额外的暑期奖学金 研究表明,本科生。
B2B 项目等研究经验对 UR 团队具有重要的积极影响,我们预计
我们的 SWID B2B 计划将产生持久影响,改变 UR 学生的生活并提高他们的成功率
当他们进入生物医学职业时。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHERYL LYNN JORCYK其他文献
CHERYL LYNN JORCYK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHERYL LYNN JORCYK', 18)}}的其他基金
The Southwest Idaho Bridges to the Baccalaureate
爱达荷州西南部通往学士学位的桥梁
- 批准号:
10252895 - 财政年份:2017
- 资助金额:
$ 6.5万 - 项目类别:
The Southwest Idaho Bridges to the Baccalaureate
爱达荷州西南部通往学士学位的桥梁
- 批准号:
10193707 - 财政年份:2017
- 资助金额:
$ 6.5万 - 项目类别:
The Southwest Idaho Bridges to the Baccalaureate
爱达荷州西南部通往学士学位的桥梁
- 批准号:
10013262 - 财政年份:2017
- 资助金额:
$ 6.5万 - 项目类别:
ONCOSTATIN M INDUCES VEGF IN HUMAN BREAST CARCINOMA CELLS
制瘤素 M 在人乳腺癌细胞中诱导 VEGF
- 批准号:
7959937 - 财政年份:2009
- 资助金额:
$ 6.5万 - 项目类别:
ONCOSTATIN M INDUCES VEGF IN HUMAN BREAST CARCINOMA CELLS
制瘤素 M 在人乳腺癌细胞中诱导 VEGF
- 批准号:
7720022 - 财政年份:2008
- 资助金额:
$ 6.5万 - 项目类别:
ONCOSTATIN M INDUCES VEGF IN HUMAN BREAST CARCINOMA CELLS
制瘤素 M 在人乳腺癌细胞中诱导 VEGF
- 批准号:
7609924 - 财政年份:2007
- 资助金额:
$ 6.5万 - 项目类别:
ONCOSTATIN M INDUCES VEGF IN HUMAN BREAST CARCINOMA CELLS
制瘤素 M 在人乳腺癌细胞中诱导 VEGF
- 批准号:
7381315 - 财政年份:2006
- 资助金额:
$ 6.5万 - 项目类别:
Oncostatin M stimulates VEGF-mediated angiogenesis
制瘤素 M 刺激 VEGF 介导的血管生成
- 批准号:
6848627 - 财政年份:2005
- 资助金额:
$ 6.5万 - 项目类别:
相似国自然基金
基于数据与知识驱动的湍流深度特征提取与本构关系建模
- 批准号:12372288
- 批准年份:2023
- 资助金额:53 万元
- 项目类别:面上项目
面向卫星重力数据反演高精度地表质量变化模型的约束模型构建及优化
- 批准号:42304097
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
物理-数据混合驱动的复杂曲面多模态视觉检测理论与方法
- 批准号:52375516
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
面向数据中心光交换端网融合调度与协同控制技术研究
- 批准号:62301062
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
缺失聚类数据的分布式保形预测问题研究
- 批准号:12371265
- 批准年份:2023
- 资助金额:43.5 万元
- 项目类别:面上项目
相似海外基金
ESTEEMED Scholars Program at the University of Rhode Island
罗德岛大学尊敬的学者计划
- 批准号:
10653461 - 财政年份:2023
- 资助金额:
$ 6.5万 - 项目类别:
U-RISE at University of Puerto Rico at Cayey
波多黎各大学凯伊分校 U-RISE
- 批准号:
10628886 - 财政年份:2023
- 资助金额:
$ 6.5万 - 项目类别:
Multi-Track Post-Baccalaureate Research Education Program (MT PREP)
多轨学士后研究教育计划 (MT PREP)
- 批准号:
10556791 - 财政年份:2023
- 资助金额:
$ 6.5万 - 项目类别:
Dental-Biomedical Engineering Scholars Training (D-Best) Program
牙科生物医学工程学者培训(D-Best)计划
- 批准号:
10845831 - 财政年份:2023
- 资助金额:
$ 6.5万 - 项目类别: